Optiver Holding’s Taysha Gene Therapies TSHA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$4.77K	Buy	2,065 +1,260	+157%	+$2.91K	﹤0.01%	904
2025 Q1	$1.12K	Sell	805 -548	-41%	-$762	﹤0.01%	997
2024 Q4	$2.34K	Buy	1,353 +747	+123%	+$1.29K	﹤0.01%	611
2024 Q3	$1.22K	Buy	+606	New	+$1.22K	﹤0.01%	569